Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Meister

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Pathology|July 17, 2015
Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cellsBenedikt Müller, Michael Bovet, Yi Yin, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissueSandra Gottschling, Anna Jauch, Ruprecht Kuner, et al.
Molecular Systems Biology|November 29, 2017
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterationsJulia Jabs, Franziska M Zickgraf, Jeongbin Park, et al.
Cancers|April 16, 2020
Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced StagesFlorian Janke, Farastuk Bozorgmehr, Sabine Wrenger, et al.
Plos One|September 27, 2017
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutationJing Zhao, Julien Dinkel, Arne Warth, et al.
Cold Spring Harbor Molecular Case Studies|November 23, 2019
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in <i>KLC1-ALK</i>-rearranged lung cancerSteffen Dietz, Petros Christopoulos, Lisa Gu, et al.
Clinical Proteomics|August 13, 2014
Validation of a blood protein signature for non-small cell lung cancerMichael R Mehan, Stephen A Williams, Jill M Siegfried, et al.
International Journal of Cancer|March 19, 2015
Non-small cell lung cancer is characterized by dramatic changes in phospholipid profilesEyra Marien, Michael Meister, Thomas Muley, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2012
The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)Sandra Gottschling, Esther Herpel, Wilfried E E Eberhardt, et al.
Cancers|September 7, 2019
Clinical Significance of <i>SERPINA1</i> Gene and Its Encoded Alpha1-antitrypsin Protein in NSCLCEvrim Ercetin, Sarah Richtmann, Beatriz Martinez Delgado, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Pathology|July 17, 2015
Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cellsBenedikt Müller, Michael Bovet, Yi Yin, et al.
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissueSandra Gottschling, Anna Jauch, Ruprecht Kuner, et al.
Molecular Systems Biology|November 29, 2017
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterationsJulia Jabs, Franziska M Zickgraf, Jeongbin Park, et al.
Cancers|April 16, 2020
Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced StagesFlorian Janke, Farastuk Bozorgmehr, Sabine Wrenger, et al.
Plos One|September 27, 2017
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutationJing Zhao, Julien Dinkel, Arne Warth, et al.
Cold Spring Harbor Molecular Case Studies|November 23, 2019
Serial liquid biopsies for detection of treatment failure and profiling of resistance mechanisms in <i>KLC1-ALK</i>-rearranged lung cancerSteffen Dietz, Petros Christopoulos, Lisa Gu, et al.
Clinical Proteomics|August 13, 2014
Validation of a blood protein signature for non-small cell lung cancerMichael R Mehan, Stephen A Williams, Jill M Siegfried, et al.
International Journal of Cancer|March 19, 2015
Non-small cell lung cancer is characterized by dramatic changes in phospholipid profilesEyra Marien, Michael Meister, Thomas Muley, et al.
Lung Cancer (Amsterdam, Netherlands)|April 10, 2012
The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)Sandra Gottschling, Esther Herpel, Wilfried E E Eberhardt, et al.
Cancers|September 7, 2019
Clinical Significance of <i>SERPINA1</i> Gene and Its Encoded Alpha1-antitrypsin Protein in NSCLCEvrim Ercetin, Sarah Richtmann, Beatriz Martinez Delgado, et al.
Pageof 12